Tudor Investment Corp
SNDX icon

Tudor Investment Corp’s Syndax Pharmaceuticals SNDX Stock Holding History

Tudor Investment Corp’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Buy
69,059
+21,638
+46% +$470K ﹤0.01% 2009
2025
Q4 		$996K Sell
47,421
-2,763
-6% -$48.2K ﹤0.01% 2275
2025
Q3 		$772K Sell
50,184
-2,872
-5% -$37.6K ﹤0.01% 2440
2025
Q2 		$497K Sell
53,056
-13,932
-21% -$153K ﹤0.01% 2606
2025
Q1 		$823K Buy
+66,988
New +$945K ﹤0.01% 1943
2024
Q4 		– Sell
-43,070
Closed -$829K – 3473
2024
Q3 		$829K Sell
43,070
-4,083
-9% -$84.4K ﹤0.01% 1737
2024
Q2 		$968K Buy
+47,153
New +$987K 0.01% 1477
2024
Q1 		– Sell
-68,981
Closed -$1.49M – 2747
2023
Q4 		$1.49M Buy
68,981
+39,042
+130% +$600K 0.01% 1256
2023
Q3 		$435K Buy
+29,939
New +$566K ﹤0.01% 1740
2023
Q1 		– Sell
-16,581
Closed -$422K – 2916
2022
Q4 		$422K Buy
+16,581
New +$387K 0.01% 1699

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Tudor Investment Corp's SNDX Position: Q1 2026 in Review

Tudor Investment Corp increased its Syndax Pharmaceuticals (SNDX) stake by 46% in Q1 2026, buying an estimated $470K and bringing the position to 69,059 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Tudor Investment Corp first reported a position in SNDX in Q4 2022 and has held it in 10 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Tudor Investment Corp held 69,059 shares of Syndax Pharmaceuticals worth $1.61M as of Q1 2026.
  • Tudor Investment Corp bought 21,638 Syndax Pharmaceuticals shares in Q1 2026, an estimated $470K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2009 holding.
  • Tudor Investment Corp first reported a position in Syndax Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.